The Centers for Medicare & Medicaid Services today awarded $8.6 million to 30 states and the District of Columbia to provide state insurance regulators with the opportunity to enhance states’ ability to strengthen their health insurance markets through innovative measures. CMS said states can use the funds, which include individual grants ranging from $225,000 to $285,000, to conduct economic analyses and market scans of the state’s health insurance market to improve and expand the number of affordable health care coverage options under new flexibilities offered to states by CMS guidance and regulations. States also can use the funds to examine plan policies, procedures and claims-related data related to access to mental health and substance use disorder treatment services, including opioid treatment services. “We recognize that states are in the best position to assess the needs of their consumers and develop innovative measures to ensure access to affordable health coverage,” said CMS Administrator Seema Verma. The funding is part of $250 million for State Rate Review Grants provided by the Affordable Care Act to improve the process for how states review proposed health insurance rates. The funds announced today are unspent Rate Review Grant funding from prior years. Click here to see how the funding is allocated to each state.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The U.S. Departments of Labor, Health and Human Services, and the Treasury announced Aug. 7 that they are reconsidering the definition of short-term, limited-…
Headline
A new analysis published Aug. 6 by the Peterson Center on Healthcare and KFF found that Health Insurance Marketplace insurers will propose a median premium…
Perspective
House members are back in their districts for the August recess and senators are likely to return to their states soon.While lawmakers are home, it’s important…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…